Role of Nuclear Imaging in Regenerative Cardiology

Cardiology Clinics

Volumn 27, Issue 2, 2009, Pages 355-367

  Lautamäki, Riikka ^a,b   Bengel, Frank M ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cell labeling; Nuclear cardiology; PET; SPECT; Stem cells

Indexed keywords

ACETIC ACID C 11; AMMONIA N 13; DOBUTAMINE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; THALLIUM 201;

ACUTE HEART INFARCTION; ANGIOGRAPHY; CARDIOLOGY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; HEART FAILURE; HEART MUSCLE; HUMAN; IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REGENERATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL; STEM CELL TRANSPLANTATION; STRESS ECHOCARDIOGRAPHY;

ANIMALS; CARDIOLOGY; HEART DISEASES; HUMANS; REGENERATIVE MEDICINE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 62549100876     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2008.12.005     Document Type: Review

References (71)

1. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
2. Xu C., Police S., Rao N., et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91 (2002) 501-508
3. Kehat I., Kenyagin-Karsenti D., Snir M., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 (2001) 407-414
4. Winitsky S.O., Gopal T.V., Hassanzadeh S., et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol e87 (2005) 662-671
5. Oshima H., Payne T.R., Urish K.L., et al. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12 (2005) 1130-1141
6. Planat-Benard V., Menard C., Andre M., et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94 (2004) 223-229
7. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10 (2004) 494-501
8. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
9. Rota M., Kajstura J., Hosoda T., et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A 104 (2007) 17783-17788
10. Fazel S., Cimini M., Chen L., et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116 (2006) 1865-1877
11. Smith R.R., Barile L., Cho H.C., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 (2007) 896-908
12. Barbash I.M., Chouraqui P., Baron J., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108 (2003) 863-868
13. Chin B.B., Nakamoto Y., Bulte J.W., et al. 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun 24 (2003) 1149-1154
14. Aicher A., Brenner W., Zuhayra M., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107 (2003) 2134-2139
15. Kraitchman D.L., Tatsumi M., Gilson W.D., et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112 (2005) 1451-1461
16. Hofmann M., Wollert K.C., Meyer G.P., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
17. Kang W.J., Kang H.J., Kim H.S., et al. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med 47 (2006) 1295-1301
18. Penicka M., Lang O., Widimsky P., et al. One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction. Heart 93 (2007) 837-841
19. Doyle B., Kemp B.J., Chareonthaitawee P., et al. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med 48 (2007) 1708-1714
20. Wu J.C., Chen I.Y., Sundaresan G., et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108 (2003) 1302-1305
21. Cao F., Lin S., Xie X., et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113 (2006) 1005-1014
22. Terrovitis J., Kwok K.F., Lautamaki R., et al. Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by SPECT or PET. J Am Coll Cardiol 52 20 (2008) 1652-1660
23. Bengel F.M., Schachinger V., and Dimmeler S. Cell-based therapies and imaging in cardiology. Eur J Nucl Med Mol Imaging 32 Suppl 2 (2005) S404-S416
24. Frank J.A., Miller B.R., Arbab A.S., et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228 (2003) 480-487
25. Wunderbaldinger P., Josephson L., and Weissleder R. Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad Radiol 9 Suppl 2 (2002) S304-S306
26. Hinds K.A., Hill J.M., Shapiro E.M., et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102 (2003) 867-872
27. Terrovitis J., Stuber M., Youssef A., et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 117 (2008) 1555-1562
28. Beeres S.L., Bengel F.M., Bartunek J., et al. Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol 49 (2007) 1137-1148
29. Brenner W., Aicher A., Eckey T., et al. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 45 (2004) 512-518
30. Bengel F.M., Anton M., Avril N., et al. Uptake of radiolabeled 2′-fluoro-2′-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging. Circulation 102 (2000) 948-950
31. Miyagawa M., Beyer M., Wagner B., et al. Cardiac reporter gene imaging using the human sodium/iodide symporter gene. Cardiovasc Res 65 (2005) 195-202
32. Wu J.C., Inubushi M., Sundaresan G., et al. Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106 (2002) 180-183
33. Inubushi M., Wu J.C., Gambhir S.S., et al. Positron-emission tomography reporter gene expression imaging in rat myocardium. Circulation 107 (2003) 326-332
34. Krishnan M., Park J.M., Cao F., et al. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J 20 (2006) 106-108
35. Dohan O., De l V., Paroder V., et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24 (2003) 48-77
36. van der Bogt K.E., Sheikh A.Y., Schrepfer S., et al. Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 118 (2008) S121-S129
37. Schachinger V., Aicher A., Dobert N., et al. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 118 (2008) 1425-1432
38. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
39. Meluzin J., Janousek S., Mayer J., et al. Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. Int J Cardiol 128 (2008) 185-192
40. Assmus B., Schachinger V., Teupe C., et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
41. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 (2004) 1690-1699
42. Dobert N., Britten M., Assmus B., et al. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur J Nucl Med Mol Imaging 31 (2004) 1146-1151
43. Bartunek J., Vanderheyden M., Vandekerckhove B., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112 (2005) I178-I183
44. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
45. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
46. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
47. Kaminek M., Meluzin J., Panovsky R., et al. Individual differences in the effectiveness of intracoronary bone marrow cell transplantation assessed by gated sestamibi SPECT/FDG PET imaging. J Nucl Cardiol 15 (2008) 392-399
48. Beeres S.L., Bax J.J., bbets-Schneider P., et al. Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results. Am Heart J 152 (2006) 684-686
49. Beeres S.L., Bax J.J., Dibbets P., et al. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia. J Nucl Med 47 (2006) 574-580
50. Strauer B.E., Brehm M., Zeus T., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 46 (2005) 1651-1658
51. Erbs S., Linke A., Adams V., et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 97 (2005) 756-762
52. Herreros J., Prosper F., Perez A., et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24 (2003) 2012-2020
53. Gavira J.J., Herreros J., Perez A., et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 131 (2006) 799-804
54. Stamm C., Kleine H.D., Choi Y.H., et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133 (2007) 717-725
55. Mocini D., Staibano M., Mele L., et al. Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. Am Heart J 151 (2006) 192-197
56. Fuchs S., Satler L.F., Kornowski R., et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 41 (2003) 1721-1724
57. Perin E.C., Dohmann H.F., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
58. Perin E.C., Dohmann H.F., Borojevic R., et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110 (2004) II213-II218
59. Britten M.B., Abolmaali N.D., Assmus B., et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108 (2003) 2212-2218
60. Fernandez-Aviles F., San Roman J.A., Garcia-Frade J., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95 (2004) 742-748
61. Ge J., Li Y., Qian J., et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 92 (2006) 1764-1767
62. Kang H.J., Kim H.S., Zhang S.Y., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
63. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
64. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
65. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
66. Assmus B., Honold J., Schachinger V., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355 (2006) 1222-1232
67. Beeres S.L., Bax J.J., Kaandorp T.A., et al. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia. Am J Cardiol 97 (2006) 1326-1331
68. Fuchs S., Kornowski R., Weisz G., et al. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol 97 (2006) 823-829
69. Ince H., Petzsch M., Rehders T.C., et al. Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J Endovasc Ther 11 (2004) 695-704
70. Katritsis D.G., Sotiropoulou P.A., Karvouni E., et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 65 (2005) 321-329
71. Menasche P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1189-1200